Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Bex

Showing results (1-10 of 331) with videos related to

Pageof 34
Sort By:
The Lancet. Oncology|December 8, 2019
Sequencing therapy for advanced renal cancerAxel Bex
The Lancet. Oncology|April 20, 2013
New options for second-line therapy of advanced renal cancerAxel Bex
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Integrating metastasectomy and stereotactic radiosurgery in the treatment of metastatic renal cell carcinomaAxel Bex
European Urology Focus|July 21, 2017
Follow-up for Renal Cell Carcinoma: Absence of Evidence and BeyondAxel Bex
European Urology|March 1, 2011
Translating translational repression: evolving possibilities in uro-oncologyAxel Bex
The Lancet. Oncology|September 11, 2012
Choosing the right option for renal-cell carcinomaAxel Bex
Cancer|March 25, 2021
Increasing the evidence for surveillance of metastatic renal cancerAxel Bex
The Lancet. Oncology|June 10, 2016
New options in treatment of advanced renal cancerAxel Bex
Clinical Advances in Hematology & Oncology : H&O|June 3, 2008
Review: treatment of small cell carcinoma of the urinary bladder: can we learn from small cell lung cancer?Axel Bex
European Urology|April 11, 2007
Editorial comment on: Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortalityAxel Bex
Pageof 34

Showing results (1-10 of 331) with videos related to

Sort By:
Pageof 34
The Lancet. Oncology|December 8, 2019
Sequencing therapy for advanced renal cancerAxel Bex
The Lancet. Oncology|April 20, 2013
New options for second-line therapy of advanced renal cancerAxel Bex
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Integrating metastasectomy and stereotactic radiosurgery in the treatment of metastatic renal cell carcinomaAxel Bex
European Urology Focus|July 21, 2017
Follow-up for Renal Cell Carcinoma: Absence of Evidence and BeyondAxel Bex
European Urology|March 1, 2011
Translating translational repression: evolving possibilities in uro-oncologyAxel Bex
The Lancet. Oncology|September 11, 2012
Choosing the right option for renal-cell carcinomaAxel Bex
Cancer|March 25, 2021
Increasing the evidence for surveillance of metastatic renal cancerAxel Bex
The Lancet. Oncology|June 10, 2016
New options in treatment of advanced renal cancerAxel Bex
Clinical Advances in Hematology & Oncology : H&O|June 3, 2008
Review: treatment of small cell carcinoma of the urinary bladder: can we learn from small cell lung cancer?Axel Bex
European Urology|April 11, 2007
Editorial comment on: Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortalityAxel Bex
Pageof 34